News Column

Technology firms vie to bring health apps to afflicted

June 23, 2014



SAN FRANCISCO: For decades, medical technology firms have searched for ways to let diabetics check blood sugar easily, with scant success. Now, the world's largest mobile technology firms are getting in on the act.

Apple Inc, Samsung Electronics Co and Google Inc, searching for applications that could turn nascent wearable technology like smartwatches and bracelets from curiosities into must-have items, have all set their sites on monitoring blood sugar.

These firms are variously hiring medical scientists and engineers, asking US regulators about oversight and developing glucose-measuring features in future wearable devices.

The first round of technology may be limited, but eventually the companies could compete in a global blood-sugar tracking market worth over $12 billion (R128bn) by 2017, according to research firm GlobalData.

Diabetes afflicts 29 million Americans and costs the economy some $245 billion in 2012, a 41 percent rise in five years. Many diabetics prick their fingers as often as 10 times daily in order to check glucose levels.

Non-invasive technology could take many forms. Electricity or ultrasound could pull glucose through the skin for measurement, for instance, or a light could be shined through the skin so that a spectroscope could measure for indications of glucose.

"All the biggies want glucose on their phone," said John Smith, former chief scientific officer of Johnson & Johnson'sLifeScan, which makes blood glucose monitoring supplies. "Get it right, and there's an enormous pay-off."

Apple, Google and Samsung declined to comment, but Courtney Lias, director at the US Food and Drug Administration's chemistry and toxicology devices division, said a marriage between mobile devices and glucose-sensing is "made in heaven".

In a December meeting with Apple executives, the FDA described how it may regulate a glucometer that measures blood sugar, according to an FDA summary of the discussion.

Such a device could avoid regulation if used for nutrition, but if marketed to diabetics, it likely would be regulated as a medical device.

The tech companies are likely to start off focusing on non-medical applications, such as fitness and education.

Even an educational device would need a breakthrough from current technology, though, and some in the medical industry say the tech firms, new to the medical world, don't understand the core challenges.

"There is a cemetery full of efforts" to measure glucose in a non-invasive way, said DexCom chief executive Terrance Gregg, whose firm is known for minimally invasive techniques.

To succeed would require "several hundred million dollars or even a billion dollars", he said.

To this end, Silicon Valley is already opening its vast wallet. - Reuters

Cape Argus


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Cape Argus (South Africa)


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters